From these results, we confirmed that the newly synthesized CCY-5 has a remarkable targetability towards cancer cells over normal cells concerning the COX-2 levels, and it can be used as a selective bio-imaging agent for cancer cells. This evidence concerns the gene PTGS2 and cancer.